TB vaccine development: monitoring international patent filings to anticipate access challenges
Maps international patent filings for two late-stage TB vaccine candidates, MTBVAC and M72/AS01E, as well as the QS-21 adjuvant used in M72/AS01E
TB vaccine theme
Project details
Country
Angola, Bangladesh, Brazil, CD, Central African Republic, Chile, China, Congo, Ethiopia, Gabon, India, Indonesia, Kenya, Lesotho, Liberia, Mexico, Mongolia, Mozambique, Myanmar, Namibia, Nigeria, North Korea, Pakistan, Papua New Guinea, Philippines, Sierra Leone, South Africa, Tanzania, Thailand, Uganda, Vietnam, Zambia
Timeline
Target group
Type of protection of vaccine
Type of research
Partners involved
Consejo Nacional de Investigaciones CientÃficas y Técnicas, Graduate Institute of International and Development Studies, Intellectual Property Scientific Research Institute of the National Academy of Legal Sciences of Ukraine, International Treatment Preparedness Coalition Global, TAG, Universidad de Buenos Aires